Clinical Evaluation of Accommodative Intraocular Lens Implantation in High Myopic Eyes

Purpose: To compare the clinical outcome of AT‐45 implantation between high myopic eyes and non‐high myopic eyes. Methods: Retrospective, non‐randomized, comparative trial. The medical charts of 28 patients with 35 eyes who had phacoemulsification and AT‐45 implantation were retrospectively reviewed. 13 eyes of 10 patients were included in the high myopic group (axial length ≥ 26.0 mm) and 22 eyes of 18 patients were included in the non‐high myopic group. The clinical data included unilateral best‐corrected visual acuity (BCVA) and distance‐corrected near visual acuity (DCNVA) at 6‐months follow‐up after the surgery. The results were compared between the two groups. Results: In the non‐high myopic group, 22 eyes (100%) and 19 eyes (86.4%) achieved a BCVA of 20/25 and 20/20 or better respectively. For the high myopic group, the results were 13 eyes (100%) and 12 eyes (92.3%) respectively, at 6 months after the surgery. In the non‐high myopic group, 21 (95.4%) and 7 eyes (31.8%) achieved a DCNVA of 20/40 and 20/25 or better. For the high myopic group, the results were 13 (100%) and 4 eyes (30.8%) respectively, at 6 months after the surgery, the differences between the two groups for a BCVA of 20/25 or better and 20/20 or better and a DCNVA 20/40 or better and 20/25 or better were not statistically significant. Conclusions: Six months clinical outcome of cataract surgery with an AT‐45 for the high myopic eyes was satisfactory; it was not significantly different from that of the non‐high myopic eyes.